Mirjam A G Sprangers Selected Research

Mirjam A G Sprangers Research Topics

22	Neoplasms (Cancer) 10/2023 - 01/2006
4	Breast Neoplasms (Breast Cancer) 01/2020 - 06/2007
3	Pain (Aches) 05/2024 - 09/2014
3	Esophageal Neoplasms (Esophageal Cancer) 01/2023 - 01/2018
2	Barrett Esophagus (Barrett's Esophagus) 01/2019 - 02/2017
2	Fatigue 01/2018 - 01/2017
2	Ulcerative Colitis 07/2014 - 12/2013
2	Infections 08/2007 - 01/2006
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 12/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 06/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022
1	Malignant Mesothelioma 01/2022
1	Postoperative Pain 03/2021
1	Prostatic Neoplasms (Prostate Cancer) 02/2021
1	Stomach Neoplasms (Stomach Cancer) 10/2020
1	Mental Disorders (Mental Disorder) 01/2020
1	Overweight 01/2018
1	Diabetes Mellitus 01/2018
1	Rectal Neoplasms (Rectal Cancer) 07/2015
1	Neoplasm Metastasis (Metastasis) 03/2015
1	Inflammation (Inflammations) 09/2014
1	HIV Infections (HIV Infection) 08/2014
1	Colitis 12/2013
1	Congenital Heart Defects (Congenital Heart Defect) 08/2013
1	Cardiovascular Diseases (Cardiovascular Disease) 09/2012
1	Colonic Neoplasms (Colon Cancer) 12/2011
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2010
1	Crohn Disease (Crohn's Disease) 08/2008
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 08/2008
1	Ileitis 08/2008
1	Hirschsprung Disease (Hirschsprung's Disease) 08/2006
1	Venous Thromboembolism 12/2004
1	Venous Thrombosis (Deep-Vein Thrombosis) 07/2003
1	Hemorrhage 07/2003

2	Proteins (Proteins, Gene)FDA Link 02/2021 - 01/2018
2	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 01/2020 - 02/2017
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 12/2013
2	Vitamin K FDA Link 12/2004 - 07/2003
1	Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA 06/2022
1	Gemcitabine FDA Link 01/2022
1	raltitrexed (D 1694)IBA 01/2022
1	Cisplatin (Platino)FDA LinkGeneric 01/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2022
1	Genetic Markers (Genetic Marker)IBA 02/2021
1	amsonic acid (DAS)IBA 01/2020
1	Interferon-gamma (Interferon, gamma)IBA 01/2018
1	Antineoplastic Agents (Antineoplastics)IBA 01/2016
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2015
1	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 09/2014
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2014
1	C-Reactive ProteinIBA 12/2013
1	Prostaglandins AIBA 12/2013
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2012
1	SteroidsIBA 08/2008
1	Immunomodulating AgentsIBA 08/2008
1	Infliximab (Remicade)FDA Link 08/2008

10	Therapeutics 10/2020 - 12/2004
7	Radiotherapy 01/2018 - 10/2008
6	Aftercare (After-Treatment) 01/2020 - 08/2013
4	Highly Active Antiretroviral Therapy (HAART) 08/2014 - 01/2006
3	Chemoradiotherapy 01/2023 - 01/2018
2	Sternotomy 05/2024 - 03/2021
2	Length of Stay 10/2023 - 03/2021
2	Esophagectomy 12/2022 - 11/2021
2	Palliative Care (Palliative Therapy) 06/2022 - 01/2006
2	Drug Therapy (Chemotherapy) 01/2020 - 07/2015
2	Mastectomy (Mammectomy) 01/2020 - 09/2015
1	Conversion to Open Surgery 10/2023
1	Critical Care (Surgical Intensive Care) 10/2023
1	Pancreaticoduodenectomy 10/2023
1	Operative Time 10/2023
1	Gastrectomy 12/2022
1	Radiofrequency Ablation 01/2019
1	Neoadjuvant Therapy 01/2018
1	Dental Care 10/2016
1	Mammaplasty (Breast Reconstruction) 09/2015
1	Lymph Node Excision (Lymph Node Dissection) 09/2015
1	Restorative Proctocolectomy 07/2014
1	Complementary Therapies (Alternative Medicine) 12/2012
1	Secondary Prevention 09/2012
1	Colectomy 12/2011
1	Immunomodulation 08/2008
1	Stents 07/2007
1	Adjuvant Chemotherapy 06/2007
1	Transition to Adult Care 08/2006
1	Duration of Therapy 07/2003